Natera
Business Services · Texas, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
Mccallen Pass Building a 13011 Ste 100, ...Phone Number
(650) 980-9190Website
www.natera.comRevenue
$2.5 BillionStock Symbol
NTRAIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
8
6
2
11
3
3
About Natera
Natera is a global leader in cell-free DNA (cfDNA) testing, focused on advancing oncology, womens health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care, helping protect health and enabling earlier, more targeted interventions that support longer, healthier lives.Explore more
Natera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Natera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Natera, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Natera launches new products
Check out if Natera is spiking on competitors!
Earning: See what the market has to say on Natera recently announced quarterly report
Funding: Get notified immidiatlly once Natera has new funding data
Check if Natera has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Natera had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Natera
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Natera as Masked Content
Find more new buyers
Compare Similar Companies to Natera
Compare insights from companies similar to Natera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Natera is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Natera is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Natera.
Natera financials insights
Gather financial insights about Natera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Grant
$2M
2012
Series D
$20M
2013
Series E
$54.6M
2015
Series F
$55.5M
Stock Offering
$180M
2018
Stock Offering
$90M
2019
Stock Offering
$100M
Stock Offering
$200M
2020
Debt
$287.5M
Natera Tech Stack
A closer look at the technologies used by Natera
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Natera News & Media
Natera’s Stronghold in Cancer Recurrence Tests Prompts Wood’s Ark to Expand Stake
Natera’s flagship product, Signatera is a personalized MRD blood test that detects cancer recurrence by identifying the unique DNA mutations.Natera Q1 Earnings Call Highlights
Natera (NASDAQ:NTRA) reported first-quarter 2026 revenue of $697 million, up 39% year over year, as the company delivered more than 1 million total units in a single quarter for the first time. Chief Executive Officer Steve Chapman said strong performance in women’s health and another record quarterNatera Inc. (NTRA): Billionaire Tom Steyer’s Stock Pick with Huge Upside Potential
We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Natera, Inc. (NASDAQ:NTRA) ranks 3rd on this list. Natera, Inc. (NASDAQ:NTRA) has been a staple in the 13F portfolio of Farallon Capital since the second quarter of 2021. Back then, this position comprised 500,000 shares. By the fourth quarter of 2022, the […]William Blair Initiates Natera (NTRA) With Outperform
Natera, Inc. (NASDAQ:NTRA) is one of the Stocks that Billionaire Druckenmiller and Jim Cramer like. William Blair initiated coverage of Natera, Inc. (NASDAQ:NTRA) with an Outperform rating on the company’s stock on April 14, 2026. The firm recommends the stock as a core, long-term growth holding. William Blair highlights Natera, Inc. (NASDAQ:NTRA)’s leadership in major […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Natera
Sign Up For FreeTo access detailed company insights
Natera is a global leader in cell-free DNA (cfDNA) testing, focused on advancing oncology, womens health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care, helping protect health and enabling earlier, more targeted interventions that support longer, healthier lives.... Read More
